SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-300102"
 

Sökning: id:"swepub:oai:DiVA.org:uu-300102" > Investigating the a...

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival

Wulaningsih, Wahyu (författare)
Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England.;Gadjah Mada Univ, Fac Med, Div Hematol Oncol, Yogyakarta, Indonesia.
Holmberg, Lars (författare)
Uppsala universitet,Endokrinkirurgi,Uppsala kliniska forskningscentrum (UCR),Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England.
Garmo, Hans (författare)
Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England.;Reg Canc Ctr, Uppsala, Sweden.
visa fler...
Karagiannis, Sophia N. (författare)
Kings Coll London, Guys & St Thomass Hosp, NIHR Biomed Res Ctr, St Johns Inst Dermatol,Div Genet & Mol Med,Fac Li, London, England.;Kings Coll London, London, England.
Ahlstedt, Staffan (författare)
Karolinska Institutet
Malmstrom, Hakan (författare)
Karolinska Institutet
Lambe, Mats (författare)
Karolinska Institutet,Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
Hammar, Niklas (författare)
Karolinska Institutet
Walldius, Goran (författare)
Karolinska Institutet
Jungner, Ingmar (författare)
Karolinska Institutet
Ng, Tony (författare)
Kings Coll London, Randall Div, Richard Dimbleby Dept Canc Res, London, England.;Kings Coll London, Div Canc Studies, London, England.
Van Hemelrijck, Mieke (författare)
Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England.;Karolinska Inst, Inst Environm Med, Epidemiol Unit, Stockholm, Sweden.
visa färre...
Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England;Gadjah Mada Univ, Fac Med, Div Hematol Oncol, Yogyakarta, Indonesia. Endokrinkirurgi (creator_code:org_t)
2016
2016
Engelska.
Ingår i: Oncoimmunology. - 2162-4011 .- 2162-402X. ; 5:6
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Prior findings linking allergy and cancer have been inconsistent, which may be driven by diverse assessment methods. We used serum specific immunoglobulin E (IgE) against common inhalant allergens that was assessed prior to cancer diagnosis in studying this association. We selected 8,727 Swedish men and women who had measurements of serum allergen-specific IgE and total IgE between 1992 and 1996. Multivariable Cox regression using age as a timescale was performed to assess the associations of IgE sensitization, defined by any levels of serum specific IgE >= 35 kU/L, with risk of overall and specific cancers. A test for trend was performed by assigning scores derived from allergen-specific IgE levels at baseline as an ordinal scale. Kaplan-Meier curves and log-rank test were used to assess cancer survival by IgE sensitization status. During a mean follow-up of 16 year, 689 persons were diagnosed with cancer. We found an inverse association between IgE sensitization and cancer risk, with a hazard ratio (HR) of 0.83 and 95% confidence intervals (CI) of 0.70-0.99. A similar trend was seen with specific IgE scores overall (P-trend = 0.007) and in women (P-trend = 0.01). Although IgE sensitization was not associated with risk of common site-specific cancers, serum specific IgE scores were inversely associated with melanoma risk in men and women combined, and with risk of female breast and gynecological cancers combined. No association with survival was observed. The association between circulating IgE levels and incident cancer may point toward a role of T-helper 2 (T(H)2)-biased response in development of some cancers.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Allergy
atopy
cancer
immunoglobulin E
cohort

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy